[go: up one dir, main page]

WO1998035680A1 - Procede de traitement de la toxicomanie et medicament homeopathique - Google Patents

Procede de traitement de la toxicomanie et medicament homeopathique Download PDF

Info

Publication number
WO1998035680A1
WO1998035680A1 PCT/RU1998/000023 RU9800023W WO9835680A1 WO 1998035680 A1 WO1998035680 A1 WO 1998035680A1 RU 9800023 W RU9800023 W RU 9800023W WO 9835680 A1 WO9835680 A1 WO 9835680A1
Authority
WO
WIPO (PCT)
Prior art keywords
morphine
drug
homeopathic
potentiated
patient
Prior art date
Application number
PCT/RU1998/000023
Other languages
English (en)
Russian (ru)
Inventor
Oleg Iliich Epshtein
Original Assignee
Oleg Iliich Epshtein
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oleg Iliich Epshtein filed Critical Oleg Iliich Epshtein
Priority to EA199900673A priority Critical patent/EA001759B1/ru
Priority to AU61264/98A priority patent/AU6126498A/en
Publication of WO1998035680A1 publication Critical patent/WO1998035680A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32—Alcohol-abuse

Definitions

  • the invention of the field of medicine may be used for medication treatment of drug addiction, including alcoholism and tobacco.
  • the method of medically treating them by administering it to a patient with neuropathic drugs is prescribed, which is prescribed in accordance with the syndrome (see I.I.
  • ⁇ dna ⁇ is ⁇ lzuemye ⁇ e ⁇ a ⁇ a ⁇ y in ⁇ sn ⁇ vn ⁇ m, an ⁇ id ⁇ - ⁇ amine ⁇ giches ⁇ ie ney ⁇ le ⁇ i ⁇ i, m ⁇ gu ⁇ u ⁇ yazhelya ⁇ ⁇ del- 5 nye sim ⁇ my and vyzyva ⁇ in b ⁇ lny ⁇ nezhela ⁇ elnye ⁇ sled- s ⁇ viya ⁇ i ⁇ e ⁇ a ⁇ ev ⁇ iches ⁇ i ⁇ d ⁇ zi ⁇ v ⁇ a ⁇ , ch ⁇ snizhae ⁇ e ⁇ - ⁇ e ⁇ ivn ⁇ s ⁇ medi ⁇ amen ⁇ zn ⁇ y ⁇ e ⁇ a ⁇ ii.
  • This medication is indicated for the treatment of emotional and non-neurological impairment and chronic drug use.
  • the finding is aimed at an increase in the effective treatment of medication (medical and / or physical illness)
  • LSD gallyutsi ⁇ gena
  • Potential drugs are included in the invention by purchasing a large amount of the 5 diluted and diluted products.
  • ⁇ as ⁇ i ⁇ aniya ⁇ g ⁇ me ⁇ a ⁇ iches ⁇ mu me ⁇ du (see., na ⁇ ime ⁇ , ⁇ .Shvabe.

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Addiction (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Psychiatry (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)

Abstract

L'invention se rapporte à un traitement médicamenteux qui utilise de la morphine potentialisée obtenue selon une méthode homéopathique au moyen de dilutions et d'agitations répétées et successives d'une substance de départ à base de morphine (un mélange d'alcaloïdes d'opium comprenant de 50 à 95 % en poids de morphine, du chlorhydrate de morphine, de l'apomorphine ou d'autres dérivés de la morphine). Il est préférable d'administrer de la morphine potentialisée, en particulier lors de manifestations aiguës liées à l'intoxication ou à l'abstinence, en combinaison avec une préparation potentialisée complémentaire, obtenue selon une méthode homéopathique mettant en oeuvre une substance de départ qui est la drogue habituelle du patient provoquant chez lui une dépendance pathologique.
PCT/RU1998/000023 1997-02-14 1998-02-09 Procede de traitement de la toxicomanie et medicament homeopathique WO1998035680A1 (fr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
EA199900673A EA001759B1 (ru) 1997-02-14 1998-02-09 Гомеопатическое лекарственное средство
AU61264/98A AU6126498A (en) 1997-02-14 1998-02-09 Method for the treatment of drug addiction and homeopathic remedy

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
RU97101895A RU2104006C1 (ru) 1997-02-14 1997-02-14 Способ лечения наркомании
RU97101895 1997-02-14

Publications (1)

Publication Number Publication Date
WO1998035680A1 true WO1998035680A1 (fr) 1998-08-20

Family

ID=20189743

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/RU1998/000023 WO1998035680A1 (fr) 1997-02-14 1998-02-09 Procede de traitement de la toxicomanie et medicament homeopathique

Country Status (4)

Country Link
AU (1) AU6126498A (fr)
EA (1) EA001759B1 (fr)
RU (1) RU2104006C1 (fr)
WO (1) WO1998035680A1 (fr)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7700096B2 (en) 2002-08-02 2010-04-20 Oleg Iliich Epshtein Medicinal agent for treating erectile dysfunction
US8535664B2 (en) 2000-06-20 2013-09-17 Oleg I. Epshtein Method of treating a pathological syndrome and a pharmaceutical agent
US8637030B2 (en) 2010-07-15 2014-01-28 Oleg I. Epshtein Combination pharmaceutical composition and methods of treating functional diseases or conditions of gastrointestinal tract
US9522116B2 (en) 2006-03-13 2016-12-20 Oleg Iliich Epshtein Solid oral form of a medicinal preparation and a method for the production thereof

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2191019C2 (ru) * 2000-08-15 2002-10-20 Малышев Вадим Геннадьевич Способ лечения абстинентного синдрома при героиновой наркомании
RU2218173C1 (ru) * 2002-07-31 2003-12-10 Матевосян Степан Нарбеевич Способ купирования абстинентного синдрома, патологического влечения и предупреждения рецидивов при кокаиновой наркомании у мужчин
GB202217676D0 (en) * 2022-11-25 2023-01-11 Rogers Gary A composition

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1990010446A1 (fr) * 1989-03-01 1990-09-20 The United States Of America, Represented By The Secretary, United States Department Of Commerce Traitement de l'accoutumance a la cocaine
US5075341A (en) * 1989-12-01 1991-12-24 The Mclean Hospital Corporation Treatment for cocaine abuse
SU1706624A1 (ru) * 1988-11-24 1992-01-23 Киевский научно-исследовательский институт кардиологии им.акад.Н.Д.Стражеско Способ лечени опиумно-морфинных наркоманий

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU1706624A1 (ru) * 1988-11-24 1992-01-23 Киевский научно-исследовательский институт кардиологии им.акад.Н.Д.Стражеско Способ лечени опиумно-морфинных наркоманий
WO1990010446A1 (fr) * 1989-03-01 1990-09-20 The United States Of America, Represented By The Secretary, United States Department Of Commerce Traitement de l'accoutumance a la cocaine
US5075341A (en) * 1989-12-01 1991-12-24 The Mclean Hospital Corporation Treatment for cocaine abuse

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8535664B2 (en) 2000-06-20 2013-09-17 Oleg I. Epshtein Method of treating a pathological syndrome and a pharmaceutical agent
US8871203B2 (en) 2000-06-20 2014-10-28 Oleg I. Epshtein Method of treating a pathological syndrome and a pharmaceutical agent
US8894995B2 (en) 2000-06-20 2014-11-25 Oleg Iliich Epshtein Method of treating a disorder or condition of viral etiology
US9382332B2 (en) 2000-06-20 2016-07-05 Oleg Iliich Epshtein Method of treating a pathological syndrome and a pharmaceutical agent
US7700096B2 (en) 2002-08-02 2010-04-20 Oleg Iliich Epshtein Medicinal agent for treating erectile dysfunction
US8168182B2 (en) 2002-08-02 2012-05-01 Oleg Iliich Epshtein Method for treating erectile dysfunction
US9522116B2 (en) 2006-03-13 2016-12-20 Oleg Iliich Epshtein Solid oral form of a medicinal preparation and a method for the production thereof
US8637030B2 (en) 2010-07-15 2014-01-28 Oleg I. Epshtein Combination pharmaceutical composition and methods of treating functional diseases or conditions of gastrointestinal tract

Also Published As

Publication number Publication date
EA001759B1 (ru) 2001-08-27
AU6126498A (en) 1998-09-08
RU2104006C1 (ru) 1998-02-10
EA199900673A1 (ru) 2000-02-28

Similar Documents

Publication Publication Date Title
Knapp et al. Postanesthetic nausea, vomiting, and retching: evaluation of the antiemetic drugs dimenhydrinate (Dramamine), chlorpromazine, and pentobarbital sodium
Winokur et al. Withdrawal reaction from long-term, low-dosage administration of diazepam: A double-blind, placebo-controlled case study
US5559152A (en) Pharmaceutical composition having antiacoholic activity
EP3813828A1 (fr) Méthodes de traitement de l'agitation faisant appel à du chlorhydrate de dexmédétomidine
RU2210360C1 (ru) Психотропное средство
US5766596A (en) Aconite tuber-sulphur composite preparation and a process for the preparation thereof
WO1998035680A1 (fr) Procede de traitement de la toxicomanie et medicament homeopathique
Simmonds et al. Anaphylaxis after oral penicillin
JP4272885B2 (ja) コカイン依存症治療用薬剤
RU2103999C1 (ru) Способ лечения алкоголизма
Sloane et al. The use of imipramine (tofranil) for depressive states in open ward settings of a general hospital: a preliminary report
Palmer et al. Prolonged narcosis as therapy in the psychoses
MAY et al. Dormison, a new type of hypnotic: its therapeutic use in psychiatric patients
Turle An investigation into the therapeutic action of hydroxyzine (Atarax) in the treatment of nervous disorders and the control of the tobacco-habit
RU2150938C1 (ru) Способ лечения опийной наркомании
Van Deth et al. Was late-nineteenth-century nervous vomiting an early variant of bulimia nervosa?
Blachly Procedure for withdrawal of barbiturates
Cho et al. Acute Heart Failure after Oral Intake of Liquid Nicotine
Curran The symptoms and treatment of barbiturate intoxication and psychosis
RU2043768C1 (ru) Способ лечения алкоголизма
Yadav Pharmacology & toxicology
RU2739192C1 (ru) Способ лечения абстинентного синдрома, с целью превенции развития психоза, у лиц с зависимостью от синтетических агонистов рецепторов гамма-аминомасляной кислоты: бутиролактона, 1,4-бутандиола
RU2788894C1 (ru) Способ лечения абстинентных психозов у лиц с зависимостью от седативных и снотворных средств, относящихся к группе синтетических агонистов рецепторов гамма-аминомасляной кислоты, бутиролактона и 1,4-бутандиола
Sargant et al. Discussion on sedation and stimulation of man.
RU2162325C1 (ru) Средство для коррекции нарушений сна у наркоманов

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GE HU IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK TJ TM TR TT UA UG US UZ VN

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GH GM KE LS MW SD SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN ML MR NE SN TD TG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 199900673

Country of ref document: EA

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

NENP Non-entry into the national phase

Ref document number: 1998535636

Country of ref document: JP

122 Ep: pct application non-entry in european phase